Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision? . (8th April 2022)

Record Type:: Journal Article
Title:: Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision? . (8th April 2022)
Main Title:: Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision?
Authors:: Jakobs, Kai
Rauch, Ursula
Abstract:: Graphical Abstract: Graphical Abstract Scheme for plasma Galectin-3 potentiating agonist-induced platelet activation and hyper-reactivity. Delineation of underlying signalling pathways. Effect of Galectin-3 inhibitor TD139 on platelet hyper-reactivity and thrombosis.
Is Part Of:: European heart journal. Volume 43:Number 37(2022)
Journal:: European heart journal
Issue:: Volume 43:Number 37(2022)
Issue Display:: Volume 43, Issue 37 (2022)
Year:: 2022
Volume:: 43
Issue:: 37
Issue Sort Value:: 2022-0043-0037-0000
Page Start:: 3575
Page End:: 3577
Publication Date:: 2022-04-08
Subjects:: Cardiology -- Periodicals
Heart -- Diseases -- Periodicals
616.12005
Journal URLs:: http://eurheartj.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/eurheartj/ehac128 ↗
Languages:: English
ISSNs:: 0195-668X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.717500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24017.xml